The Confidentiality Coalition and the Workgroup for Electronic Data Interchange (WEDI) have expressed concerns about the potential misuse of patient health information by unregulated third-party applications in a letter to the secretaries of Commerce and Health and Human Services. The groups are also worried that patients may not have sufficient information about third-party apps and the risk of their information not being protected by HIPAA. They have offered recommendations to increase security and protect privacy.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
